Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...
MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR-T cell therapy program for autoimmune diseases.
Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.
Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...
11d
News Medical on MSNResearchers develop model to identify tumor-fighting immune cells in lung cancer patientsResearchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
Immunotherapy enhances your immune system’s ability to target cancer cells. Chemotherapy acts directly on cancer cells to keep them from replicating. Immunotherapy and chemotherapy are two ...
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.
“Tumor-active T cells are very important ... The original study showed that the immunotherapy-activated immune cells share a common gene expression profile. In the new study, Zeng, Smith and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results